Seventh Circuit judges hearing former Outcome Health executives’ challenge to a $1 billion fraud conviction seemed critical of the U.S. government’s handling of the case on Tuesday as they questioned why its admitted asset over-restraint and introduction of certain grand jury...
L&L Hawaiian Barbecue, the largest Hawai‘i-based restaurant chain, continues nationwide expansion reflecting steady demand for hearty island comfort food and the continued strength of the brand’s community-centered franchise system. The company closed 2025 with 14 new franchise locations...
No pizza establishment has ever earned a MICHELIN Star and Papa Johns is leading the charge to become the first. The brand is making a statement the world can rally behind: great pizza is star-worthy. With the launch of their new Pan Pizza, Papa Johns is ready to prove it. “This is a love letter...
HTeaO, the nation’s leading iced tea franchise, announces the grand opening of its newest location in Atascocita on Saturday, February 14, 2026. Located at 17622 W. Lake Houston Pkwy, Humble, TX 77346 the new store is owned and operated by franchise owners Amanda West McGee and John McGee,...
Original story from the Baylor College of Medicine (TX, USA). What strategy does triple negative breast cancer use to boost its ability to metastasize? Researchers have found out. Researchers at Baylor College of Medicine (TX, USA) have uncovered a strategy that triple negative breast cancer...
Original story from Scripps Research Institute (CA, USA). Scientists have designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus. One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right...
The human brain – all 86 billion neurons of it – is something of an enigma. Despite decades of research, our understanding of how it works remains limited, presenting a major roadblock in the quest to treat neurological disease and mental illness – one that the emerging field of connectomics,...
Worth up to $2.4 billion, the acquisition is also the latest in a series of buyouts involving startups with technologies that modify immune cells inside the body.
Continue reading →
Lilly could pay Innovent Biologics up to $9 billion in a new alliance. Elsewhere, Roche tried to assuage investor concerns about its new multiple sclerosis drug and Roivant shares surged.
Continue reading →